ChemoMetec and Roche Diagnostics have entered a collaboration agreement to develop a connection kit linking the Roche Cedex® Bio Analyzer and the ChemoMetec Xcytomatic® 30 cell counting analyzer. The agreement follows a Letter of Intent signed in February 2026 and covers both development and subsequent commercialization of the connectivity solution. Roche will design the connection kit and handle verification and validation, aiming for seamless hardware and software integration between the two instruments. The companies will jointly promote the combined solution while each remains the sole seller of its own analyzers.
ChemoMetec A/SCollaboration to develop connectivity kit for its Xcytomatic analyzer with Roche.
Roche Holding AGPartnership to develop and commercialize connectivity solution for its Cedex Bio Analyzer.